AT&T, one of the newcomers to Mexico’s opening telecommunications sector, issued a statement this week warning its main rival, Telmex, that the Carlos Slim owned company should request authorization from the country’s telecomm regulator, IFT, before offering the Clarovideo on-demand video service as part of its package deals.
Mexico’s Federal Telecommunications Institute will have to verify that other market players, including AT&T itself, are capable of replicating the offers and bundles offered by América Móvil’s operation. Otherwise, AT&T claims the company would be engaging in unfair competition. Cristina Ruíz, head of External Affairs for AT&T’s Mexico operation elaborated, saying “the conditions for effective competition would not exist without the application of additional regulation. The lack of effective competition can have a negative effect on the welfare of Mexico’s population, as well as slowing its potential economic growth.”
The spokeswoman continued, demanding América Móvil to hand over to regulators a full roster of their passive infrastructure (such as transmission towers and poles,) and requesting it be prevented from striking exclusive deals. “The aim of the Telecommunications Reform was to reduce market concentration, making the special rules on preponderant (dominant) actors only temporary, to be removed once the dominant economic actor has sufficiently reduced their market share…”
Full Content: La Voz
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Justice Department Moves to End NCAA Transfer Rule
May 30, 2024 by
CPI
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 31, 2024 by
CPI
AI and Antitrust Considerations in U.S. Health Care
May 31, 2024 by
CPI
Uncertainty in the Bottom Line: New Antitrust Scrutiny and Enforcement in Private Equity Transactions
May 31, 2024 by
CPI
Effecting M&A Diligence When Competitors Are Involved
May 31, 2024 by
CPI
AI, Pharmaceutical Sector, and EU Competition Law and Policy: What Does the Future Look Like?
May 31, 2024 by
CPI